| Product Name | MF | CAS | Details |
|---|
| C10H11N5O3S2 | Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| 7-TMCA-YH2/ (7-TMCA-YH2) | Details |
| Details |
| Details |
| Details |
| C5H4N4O | Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| 7-TMCA-YH1/ (7-TMCA-YH1) | Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| 7-ANCA-Dimer | Details |
| Details |
| Details |
| 7-ATCA-3E/ (7-ATCA-3E) | Details |
| 7-ANCA-7S | Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Cefuroxime Sodium GSK ring opening impurity | Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| 7-ADCA-Dimer/ 7-ADCA-Dimer | Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| 7-TMCA-Dimer/ (7-TMCA-Dimer ) | Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Details |
| Product Total： Product Page： | ||||
| 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 | ||||